The drug development sector in the United States is experiencing a rapid surge in requirement for Tirzepatide APIs. This effective medication, used to treat insulin resistance, has captured considerable attention from both individuals and healthcare professionals. As a result, numerous companies have emerged as suppliers of Tirzepatide APIs in the